Peginesatide acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for peginesatide acetate and what is the scope of freedom to operate?
Peginesatide acetate
is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Peginesatide acetate has twenty-seven patent family members in eighteen countries.
Summary for peginesatide acetate
International Patents: | 27 |
US Patents: | 2 |
Tradenames: | 2 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | peginesatide acetate at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for peginesatide acetate
Generic Entry Date for peginesatide acetate*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;INTRAVENOUS, SUBCUTANEOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Anatomical Therapeutic Chemical (ATC) Classes for peginesatide acetate
US Patents and Regulatory Information for peginesatide acetate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-004 | Mar 27, 2012 | DISCN | No | No | 7,550,433 | ⤷ Try for Free | ⤷ Try for Free | ||||
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-003 | Mar 27, 2012 | DISCN | No | No | 7,550,433 | ⤷ Try for Free | ⤷ Try for Free | ||||
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-001 | Mar 27, 2012 | DISCN | No | No | 7,919,461 | ⤷ Try for Free | ⤷ Try for Free | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for peginesatide acetate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-003 | Mar 27, 2012 | 7,084,245 | ⤷ Try for Free |
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-006 | Mar 27, 2012 | 7,084,245 | ⤷ Try for Free |
Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-005 | Mar 27, 2012 | 7,528,104 | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for peginesatide acetate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 1917023 | PREPARATIONS DE PEPTIDES AGONISTES DU RECEPTEUR DE L'ERYTHROPOIETINE ET UTILISATIONS (ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES) | ⤷ Try for Free |
China | 101553242 | Erythropoietin receptor peptide formulations and uses | ⤷ Try for Free |
Japan | 2008542399 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Market Dynamics and Financial Trajectory for Peginesatide Acetate
More… ↓